Medicare Group Q.P.S.C Future Growth
Future criteria checks 1/6
Medicare Group Q.P.S.C is forecast to grow revenue at 4.6% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 18.7% |
Revenue growth rate | 4.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 24 Oct 2024 |
Recent future growth updates
Recent updates
Medicare Group Q.P.S.C's (DSM:MCGS) Returns On Capital Tell Us There Is Reason To Feel Uneasy
May 26Investors In Medicare Group Q.P.S.C. (DSM:MCGS) Should Consider This, First
Apr 08Dividend Investors: Don't Be Too Quick To Buy Medicare Group Q.P.S.C. (DSM:MCGS) For Its Upcoming Dividend
Mar 18Medicare Group Q.P.S.C.'s (DSM:MCGS) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?
Mar 09Be Wary Of Medicare Group Q.P.S.C (DSM:MCGS) And Its Returns On Capital
Feb 16Should You Use Medicare Group Q.P.S.C's (DSM:MCGS) Statutory Earnings To Analyse It?
Jan 28Can You Imagine How Medicare Group Q.P.S.C's (DSM:MCGS) Shareholders Feel About The 20% Share Price Increase?
Jan 05How Does Medicare Group Q.P.S.C. (DSM:MCGS) Fare As A Dividend Stock?
Dec 15Medicare Group Q.P.S.C.'s (DSM:MCGS) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Nov 29Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 569 | N/A | N/A | N/A | 1 |
12/31/2025 | 543 | N/A | N/A | N/A | 1 |
12/31/2024 | 522 | N/A | N/A | N/A | 1 |
9/30/2024 | 513 | 77 | 36 | 107 | N/A |
6/30/2024 | 498 | 69 | 37 | 106 | N/A |
3/31/2024 | 488 | 67 | 25 | 93 | N/A |
12/31/2023 | 486 | 66 | 24 | 88 | N/A |
9/30/2023 | 483 | 82 | 77 | 112 | N/A |
6/30/2023 | 488 | 86 | 65 | 108 | N/A |
3/31/2023 | 498 | 81 | 81 | 114 | N/A |
12/31/2022 | 487 | 79 | 58 | 103 | N/A |
9/30/2022 | 488 | 82 | 29 | 88 | N/A |
6/30/2022 | 496 | 83 | 33 | 86 | N/A |
3/31/2022 | 477 | 74 | 21 | 86 | N/A |
12/31/2021 | 484 | 79 | 40 | 99 | N/A |
9/30/2021 | 485 | 89 | 41 | 109 | N/A |
6/30/2021 | 495 | 87 | 48 | 114 | N/A |
3/31/2021 | 471 | 87 | 51 | 101 | N/A |
12/31/2020 | 477 | 86 | 63 | 115 | N/A |
9/30/2020 | 482 | 84 | 76 | 126 | N/A |
6/30/2020 | 458 | 75 | 69 | 121 | N/A |
3/31/2020 | 493 | 79 | 65 | 126 | N/A |
12/31/2019 | 491 | 78 | 66 | 121 | N/A |
9/30/2019 | 483 | 88 | 85 | 135 | N/A |
6/30/2019 | 485 | 85 | 93 | 138 | N/A |
3/31/2019 | 485 | 84 | 106 | 141 | N/A |
12/31/2018 | 484 | 85 | 111 | 140 | N/A |
9/30/2018 | 488 | 84 | 116 | 148 | N/A |
6/30/2018 | 483 | 81 | N/A | 154 | N/A |
3/31/2018 | 480 | 83 | N/A | 192 | N/A |
12/31/2017 | 471 | 80 | N/A | 187 | N/A |
9/30/2017 | 471 | 66 | N/A | 165 | N/A |
6/30/2017 | 463 | 67 | N/A | 167 | N/A |
3/31/2017 | 469 | 69 | N/A | 190 | N/A |
12/31/2016 | 469 | 65 | N/A | 184 | N/A |
9/30/2016 | 498 | 87 | N/A | 175 | N/A |
6/30/2016 | 529 | 115 | N/A | 146 | N/A |
3/31/2016 | 562 | 145 | N/A | N/A | N/A |
12/31/2015 | 596 | 180 | N/A | 148 | N/A |
9/30/2015 | 594 | 196 | N/A | N/A | N/A |
6/30/2015 | 581 | 197 | N/A | 150 | N/A |
3/31/2015 | 561 | 197 | N/A | N/A | N/A |
12/31/2014 | 528 | 182 | N/A | 119 | N/A |
9/30/2014 | 486 | 149 | N/A | N/A | N/A |
6/30/2014 | 459 | 125 | N/A | 124 | N/A |
3/31/2014 | 435 | 99 | N/A | 120 | N/A |
12/31/2013 | 418 | 89 | N/A | 96 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if MCGS's forecast earnings growth is above the savings rate (14.7%).
Earnings vs Market: Insufficient data to determine if MCGS's earnings are forecast to grow faster than the QA market
High Growth Earnings: Insufficient data to determine if MCGS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MCGS's revenue (4.6% per year) is forecast to grow faster than the QA market (3.9% per year).
High Growth Revenue: MCGS's revenue (4.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MCGS's Return on Equity is forecast to be high in 3 years time